Robert C. Ladner

4.9k total citations
48 papers, 3.3k citations indexed

About

Robert C. Ladner is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Ecology. According to data from OpenAlex, Robert C. Ladner has authored 48 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Radiology, Nuclear Medicine and Imaging, 30 papers in Molecular Biology and 8 papers in Ecology. Recurrent topics in Robert C. Ladner's work include Monoclonal and Polyclonal Antibodies Research (30 papers), Glycosylation and Glycoproteins Research (12 papers) and Advanced Biosensing Techniques and Applications (10 papers). Robert C. Ladner is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (30 papers), Glycosylation and Glycoproteins Research (12 papers) and Advanced Biosensing Techniques and Applications (10 papers). Robert C. Ladner collaborates with scholars based in United States, United Kingdom and Belgium. Robert C. Ladner's co-authors include M. F. Perutz, William Markland, William A. Goddard, Arthur C. Ley, Rachel B. Kent, Daniel J. Sexton, Aaron K. Sato, Mark de Souza, Andrew E. Nixon and Bruce Roberts and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Robert C. Ladner

48 papers receiving 3.1k citations

Peers

Countries citing papers authored by Robert C. Ladner

Since Specialization

Citations

This map shows the geographic impact of Robert C. Ladner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert C. Ladner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert C. Ladner more than expected).

Fields of papers citing papers by Robert C. Ladner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert C. Ladner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert C. Ladner. The network helps show where Robert C. Ladner may publish in the future.

Co-authorship network of co-authors of Robert C. Ladner

This figure shows the co-authorship network connecting the top 25 collaborators of Robert C. Ladner. A scholar is included among the top collaborators of Robert C. Ladner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert C. Ladner. Robert C. Ladner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PEGylated DX-1000: Pharmacokinetics and Antineoplastic Activity of a Specific Plasmin Inhibitor 2007 ·Neoplasia ·Laetitia Devy, Shafaat A. Rabbani, (unknown), (unknown), Ian Mackie, (unknown), (unknown), Reinoud van Gool, Jie Chen, (unknown), Robert C. Ladner, Daniel T. Dransfield, Paula Henderikx	28
2	Mapping the Epitopes of Antibodies 2007 ·Biotechnology and Genetic Engineering Reviews ·Robert C. Ladner	42
3	Screening isolates from antibody phage-display libraries 2007 ·Drug Discovery Today ·David R. Buckler, Albert Park, Malini Viswanathan, Rene Hoet, Robert C. Ladner	24
4	High-throughput affinity ranking of antibodies using surface plasmon resonance microarrays 2006 ·Analytical Biochemistry ·Dina Wassaf, Guannan Kuang, (unknown), Qilong Wu, Que Thanh Thanh Nguyen, (unknown), (unknown), (unknown), (unknown), Jérémy Lambert, Csaba Pazmany, Shannon Hogan, Robert C. Ladner, Andrew E. Nixon, Daniel J. Sexton	96
5	Isolation of a peptide ligand for affinity purification of factor VIII using phage display 2004 ·Journal of Chromatography A ·Brian D. Kelley, James A. Booth, (unknown), (unknown), Robert C. Ladner, (unknown), Daniel Potter, Arthur C. Ley	32
6	Phage display-derived peptides as therapeutic alternatives to antibodies 2004 ·Drug Discovery Today ·Robert C. Ladner, Aaron K. Sato, (unknown), Mark de Souza	239
7	Novel Peptide Inhibitors of Angiotensin-converting Enzyme 2 2003 ·Journal of Biological Chemistry ·Lili Huang, Daniel J. Sexton, Kirsten Skogerson, Mary Devlin, Rodger Smith, (unknown), Tom J. Parry, Rachel B. Kent, (unknown), Qilong Wu, Greg Conley, Daniel B. DeOliveira, (unknown), Matthew D. Ducar, Charles R. Wescott, Robert C. Ladner	182
8	Affinity maturation of Fab antibody fragments by fluorescent‐activated cell sorting of yeast‐displayed libraries 2003 ·FEBS Letters ·Twan van den Beucken, (unknown), Mieke Steukers, (unknown), Robert C. Ladner, Hennie R. Hoogenboom, Simon E. Hufton	78
9	Development of Mammalian Serum Albumin Affinity Purification Media by Peptide Phage Display 2002 ·Biotechnology Progress ·Aaron K. Sato, Daniel J. Sexton, (unknown), Edward H. Cohen, (unknown), Greg Conley, (unknown), (unknown), Mary Devlin, Daniel B. DeOliveira, (unknown), Rachel B. Kent, Charles R. Wescott, (unknown), Arthur C. Ley, Robert C. Ladner	73
10	Isolation, characterization, and recovery of small peptide phage display epitopes selected against viable malignant glioma cells 2001 ·Cancer Gene Therapy ·Matthew A. Spear, Xandra O. Breakefield, James Beltzer, Deborah E. Schuback, Ralph Weissleder, Francisco S. Pardo, Robert C. Ladner	33
11	Novel frameworks as a source of high-affinity ligands 2001 ·Current Opinion in Biotechnology ·Robert C. Ladner, Arthur C. Ley	28
12	[2] Selection for protease inhibitors using bacteriophage display 1996 ·Methods in enzymology on CD-ROM/Methods in enzymology ·William Markland, Bruce Roberts, Robert C. Ladner	12
13	[4] Affinity maturation of proteins displayed on surface of M13 bacteriophage as major coat protein fusions 1996 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Bruce Roberts, William Markland, Robert C. Ladner	6
14	Obtaining a family of high-affinity, high-specificity protein inhibitors of plasmin and plasma kallikrein 1996 ·Molecular Diversity ·Arthur C. Ley, William Markland, Robert C. Ladner	18
15	Constrained peptides as binding entities 1995 ·Trends in biotechnology ·Robert C. Ladner	99
16	Protease inhibitor display M13 phage: selection of high-affinity neutrophil elastase inhibitors 1992 ·Gene ·Bruce Roberts, William Markland, (unknown), (unknown), Sonia K. Guterman, Robert C. Ladner	39
17	Directed evolution of a protein: selection of potent neutrophil elastase inhibitors displayed on M13 fusion phage. 1992 ·Proceedings of the National Academy of Sciences ·Bruce Roberts, William Markland, Arthur C. Ley, Rachel B. Kent, Derek W. R. White, Sonia K. Guterman, Robert C. Ladner	155
18	Crystal and molecular structures of native and CTP-liganded aspartate carbamoyltransferase from Escherichia coli 1982 ·Journal of Molecular Biology ·Richard B. Honzatko, James L. Crawford, Hugo L. Monaco, Jane E. Ladner, (unknown), David R. Evans, Stephen G. Warren, Don C. Wiley, Robert C. Ladner, William N. Lipscomb	202
19	Generalized orbital description of the reactions of small molecules 1971 ·Journal of the American Chemical Society ·William A. Goddard, Robert C. Ladner	89
20	A new type of wavefunction for BH 1970 ·Chemical Physics Letters ·Richard J. Blint, William A. Goddard, Robert C. Ladner, William E. Palke	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact